Literature DB >> 483232

Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.

K Breddin, D Loew, K Lechner, K Uberla, E Walter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 483232

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  10 in total

1.  Oral anticoagulant in patients surviving myocardial infarction. A new approach to old data.

Authors:  A Leizorovicz; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  Aspirin in the prevention of myocardial infarction. Current status.

Authors:  P C Elwood
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

3.  Doctors' opinions on the prevention of myocardial infarction.

Authors:  M J Lichtenstein; P C Elwood; H F Thomas; P M Sweetnam
Journal:  J R Coll Gen Pract       Date:  1985-11

4.  Studies of myocardial infarction.

Authors:  B J Culliton; W K Waterfall
Journal:  Br Med J       Date:  1980-06-07

5.  Polyunsaturated fatty acids of serum lipids in myocardial infarction.

Authors:  J W Crofts; P L Ogburn; S B Johnson; R T Holman
Journal:  Lipids       Date:  1988-06       Impact factor: 1.880

Review 6.  Aspirin in cardiovascular disease.

Authors:  I A Reilly; G A FitzGerald
Journal:  Drugs       Date:  1988-02       Impact factor: 9.546

Review 7.  The role of arachidonic acid metabolites in cardiovascular homeostasis. Biochemical, histological and clinical cardiovascular effects of non-steroidal anti-inflammatory drugs and their interactions with cardiovascular drugs.

Authors:  D S Goodman
Journal:  Drugs       Date:  1987       Impact factor: 9.546

8.  Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin.

Authors:  P J Prichard; G K Kitchingman; R P Walt; T K Daneshmend; C J Hawkey
Journal:  BMJ       Date:  1989-02-25

9.  Protease and cyclooxygenase inhibitors synergistically prevent activation of human platelets.

Authors:  M Ruggiero; E G Lapetina
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

Review 10.  Long-term anticoagulation. Indications and management.

Authors:  B M Stults; W H Dere; T H Caine
Journal:  West J Med       Date:  1989-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.